These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27002311)

  • 21. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.
    Duquesnoy RJ; Awadalla Y; Lomago J; Jelinek L; Howe J; Zern D; Hunter B; Martell J; Girnita A; Zeevi A
    Transpl Immunol; 2008 Feb; 18(4):352-60. PubMed ID: 18158123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
    Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
    Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
    Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort.
    Ekong UD; Antala S; Bow L; Sese D; Morotti R; Rodriguez-Davalos M; Gan G; Deng Y; Emre SH
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):6-17. PubMed ID: 30777518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction.
    Girnita AL; Duquesnoy R; Yousem SA; Iacono AT; Corcoran TE; Buzoianu M; Johnson B; Spichty KJ; Dauber JH; Burckart G; Griffith BP; McCurry KR; Zeevi A
    Am J Transplant; 2005 Jan; 5(1):131-8. PubMed ID: 15636621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Single-Center Analysis of How HLA Mismatch and Donor-Specific Antibodies Affect Short-Term Outcome After Lung Transplantation: A Pilot Study Before a Country-Wide Histocompatibility Study in Japan.
    Hirama T; Akiba M; Watanabe T; Watanabe Y; Oishi H; Okada Y
    Transplant Proc; 2024 Mar; 56(2):363-368. PubMed ID: 38320866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity.
    Wiebe C; Kosmoliaptsis V; Pochinco D; Gibson IW; Ho J; Birk PE; Goldberg A; Karpinski M; Shaw J; Rush DN; Nickerson PW
    Am J Transplant; 2019 Jun; 19(6):1708-1719. PubMed ID: 30414349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
    Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
    J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
    Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
    Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific Donor HLA-DR Types Correlate With Altered Susceptibility to Development of Chronic Lung Allograft Dysfunction.
    Haynes LD; Julliard WA; Mezrich JD; Leverson G; Meyer KC; Burlingham WJ
    Transplantation; 2018 Jul; 102(7):1132-1138. PubMed ID: 29360666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients.
    Zhang X; Kransdorf E; Levine R; Patel JK; Kobashigawa JA
    Hum Immunol; 2020 Jul; 81(7):330-336. PubMed ID: 32307126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-G*01:04∼UTR3 Recipient Correlates With Lower Survival and Higher Frequency of Chronic Rejection After Lung Transplantation.
    Di Cristofaro J; Reynaud-Gaubert M; Carlini F; Roubertoux P; Loundou A; Basire A; Frassati C; Thomas P; Gomez C; Picard C
    Am J Transplant; 2015 Sep; 15(9):2413-20. PubMed ID: 25989360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort.
    Reindl-Schwaighofer R; Heinzel A; Kainz A; van Setten J; Jelencsics K; Hu K; Loza BL; Kammer M; Heinze G; Hruba P; Koňaříková A; Viklicky O; Boehmig GA; Eskandary F; Fischer G; Claas F; Tan JC; Albert TJ; Patel J; Keating B; Oberbauer R;
    Lancet; 2019 Mar; 393(10174):910-917. PubMed ID: 30773281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.
    Philogene MC; Amin A; Zhou S; Charnaya O; Vega R; Desai N; Neu AM; Pruette CS
    Pediatr Nephrol; 2020 Jan; 35(1):83-94. PubMed ID: 31599339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial.
    Ruttens D; Verleden SE; Vandermeulen E; Bellon H; Vanaudenaerde BM; Somers J; Schoonis A; Schaevers V; Van Raemdonck DE; Neyrinck A; Dupont LJ; Yserbyt J; Verleden GM; Vos R
    Am J Transplant; 2016 Jan; 16(1):254-61. PubMed ID: 26372728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eplet matching in pediatric heart transplantation: The SickKids experience.
    Cardoso B; Wang J; Kiernan J; Dipchand AI
    J Heart Lung Transplant; 2022 Oct; 41(10):1470-1477. PubMed ID: 35933296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eplet incompatibility in pediatric renal transplantation.
    Rãchişan AL; Dubois V; Ranchin B; Sellier-Leclerc AL; Bertholet Thomas A; Cochat P; Bacchetta J
    Pediatr Transplant; 2020 Sep; 24(6):e13721. PubMed ID: 32388894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-C mismatching improves outcomes following lung transplantation.
    Hiho SJ; Levvey BJ; Diviney MB; Brooks AG; Holdsworth R; Snell GI; Westall GP; Sullivan LC
    HLA; 2024 Jun; 103(6):e15544. PubMed ID: 38924641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcome of lung transplantation is predicted by the number of HLA-DR mismatches.
    van den Berg JW; Hepkema BG; Geertsma A; Koëter GH; Postma DS; de Boer WJ; Lems SP; van der Bij W
    Transplantation; 2001 Feb; 71(3):368-73. PubMed ID: 11233895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.